Tieu, A.; Chaigne, B.; Dunogué, B.; Dion, J.; Régent, A.; Casadevall, M.; Cohen, P.; Legendre, P.; Terrier, B.; Costedoat-Chalumeau, N.;
et al. Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted Phenotypes. Diagnostics 2022, 12, 1067.
https://doi.org/10.3390/diagnostics12051067
AMA Style
Tieu A, Chaigne B, Dunogué B, Dion J, Régent A, Casadevall M, Cohen P, Legendre P, Terrier B, Costedoat-Chalumeau N,
et al. Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted Phenotypes. Diagnostics. 2022; 12(5):1067.
https://doi.org/10.3390/diagnostics12051067
Chicago/Turabian Style
Tieu, Ashley, Benjamin Chaigne, Bertrand Dunogué, Jérémie Dion, Alexis Régent, Marion Casadevall, Pascal Cohen, Paul Legendre, Benjamin Terrier, Nathalie Costedoat-Chalumeau,
and et al. 2022. "Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted Phenotypes" Diagnostics 12, no. 5: 1067.
https://doi.org/10.3390/diagnostics12051067
APA Style
Tieu, A., Chaigne, B., Dunogué, B., Dion, J., Régent, A., Casadevall, M., Cohen, P., Legendre, P., Terrier, B., Costedoat-Chalumeau, N., Le Jeunne, C., & Mouthon, L.
(2022). Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted Phenotypes. Diagnostics, 12(5), 1067.
https://doi.org/10.3390/diagnostics12051067
